CLRB Latest Press Releases

-- April 21, 2026 --

Cellectar Biosciences Announces Subset of CLOVER WaM Clinical Trial Data Accepted for Presentation at the American Society of Clinical Oncology Conference 2026 Globe Newswire 10:00 AM

-- April 14, 2026 --

Cellectar Enrolls First Patient in CLR 125 Auger-Emitting Radioconjugate Phase 1b Clinical Trial Targeting Refractory Triple Negative Breast Cancer (TNBC) Globe Newswire 8:35 AM

-- March 4, 2026 --

Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates Globe Newswire 7:15 AM

-- February 25, 2026 --

Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday, March 4, 2026 Globe Newswire 8:05 AM

-- February 17, 2026 --

Cellectar Biosciences Expands Global Intellectual Property Estate Globe Newswire 8:05 AM

-- January 9, 2026 --

Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference Globe Newswire 8:05 AM

-- December 16, 2025 --

Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies Globe Newswire 8:05 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software